Cambridge Investment Research Advisors, Inc.
Position in BNTX — BioNTech SE
CIK 1419186
FAIRFIELD, IA
Position in BNTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$424,866
+$84,900 QoQ
Shares Held
4,566
+19.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#158
of 282 holders
Holding Since
Dec 2020
23 quarters on record
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. BNTX ranks #32 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in BNTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $424,866 | 4,566 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $339,966 | 3,825 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $363,854 | 3,822 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $371,797 | 3,770 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $451,113 | 4,237 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $395,837 | 4,347 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $496,935 | 4,361 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $543,610 | 4,577 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $355,432 | 4,423 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $408,483 | 4,428 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $391,447 | 3,709 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $432,387 | 3,980 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $413,587 | 3,832 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $395,758 | 3,177 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,187,338 | 7,904 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,089,156 | 8,075 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,258,702 | 8,442 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,507,068 | 8,836 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,824,708 | 7,078 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $978,942 | 3,586 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $767,236 | 3,427 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $663,766 | 6,079 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $447,544 | 5,490 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||